Corpus ID: 21628472

The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.

@article{Tsai1994TheIE,
  title={The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.},
  author={J. Tsai and T. F. Wang and S. Wang},
  journal={Asian Pacific journal of allergy and immunology},
  year={1994},
  volume={12 1},
  pages={
          65-71
        }
}
We have tested the effect of methotrexate (MTX) on platelet activating factor (PAF)-induced neutrophil and eosinophil locomotion, neutrophil leukotriene B4 (LTB4) generation and mononuclear cell DNA synthesis. Neutrophils from patients treated with low dose methotrexate showed reduced PAF-induced chemotactic responses (727.8 +/- 72.2/10 HPF vs 481.9 +/- 87.3/10 HPF, p < 0.05). Both MTX and the specific PAF antagonist BN-52021 significantly inhibited PAF-induced eosinophil and neutrophil… Expand
5 Citations
Alternate treatments in asthma.
Methotrexate as a steroid sparing agent for asthma in adults.
Unconventional treatment options in severe asthma: an overivew.
  • H. L. Banh
  • Medicine
  • Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
  • 2011

References

SHOWING 1-10 OF 17 REFERENCES
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions.
Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.
  • P. Borgeat, B. Samuelsson
  • Chemistry, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1979
...
1
2
...